Guidance: Standard Operating Procedures for Addressing Partner Relationships and Gender-Based Violence in Pre-Exposure Prophylaxis (PrEP) Services
Standard Operating Procedure Guidance
Evidence has shown that intimate partner violence (IPV) may act as a barrier to accessing HIV services, including PrEP services. IPV is associated with lower PrEP uptake and adherence and increased PrEP interruption among cisgender women. Although cisgender women have made up the majority of participants in research on PrEP and IPV to date, it is likely that IPV has similar impacts among other populations as well. Likewise, while other forms of gender-based violence (GBV), such as non-partner sexual violence, may have similar effects on PrEP use, less is currently known about their impact.
This standard operating procedure (SOP) guidance was developed under the USAID-funded CHARISMA project and the CHOICE collaboration of the EpiC and RISE projects and adapted for multiple PrEP methods under the USAID-funded MOSAIC project. The guidance can be used by pre-exposure prophylaxis (PrEP) program staff to screen for and address GBV in PrEP services. This resource includes guidance for adapting the SOP to the local context and clinic processes.
The SOP guidance outlines procedures for identifying clients who are experiencing GBV – especially IPV and non-partner sexual violence – and providing first-line support and referrals for clients who disclose experiences of violence. The resource also provides counseling messages to help clients decide whether to talk to their partner(s) about their PrEP use and strategies for using PrEP with or without their partner’s knowledge.
The PrEP Job Aid for Addressing Partner Relationships supports implementation of SOPs developed using the SOP guidance document. This 2-page flowchart provides step-by-step instructions for discussing partner relationships and responding to GBV with PrEP clients and instructions for adapting the job aid to the local context and clinic processes.
For questions or additional support, please contact [email protected].
Integrated Study Dashboard
This dashboard, produced under the BioPIC project, reflects all currently known activities relating to implementation research, modelling, clinical trials, open label extensions, and landscaping for new late stage biomedical HIV PrEP options, including cabotegravir for PrEP and the dapivirine vaginal ring. To update or add any activities missing from the dashboard, or if you have…
Deep Dive Review of Modelling Long Acting PrEP Meeting Summary
In March 2023, the Bill and Melinda Gates Foundation convened modellers looking into the impact, costs, and/or cost effectiveness of cabotegravir (CAB) for PrEP in low and middle income countries. This meeting summary provides an overview of 11 models as well as key insights emerging from the models and knowledge gaps.
Global Healthcare Provider Training Package for the Dapivirine Vaginal Ring
This training manual was developed by the International Partnership for Microbicides and can be adapted for contexts where the dapivirine vaginal ring is being offered. To help us understand who is using these materials, so we can ensure they remain as relevant and helpful as possible, we kindly ask anyone downloading the materials to complete…
Perception of PrEP-related Stigma in PrEP Users: Results from the ANRS-PREVENIR cohort
This journal article from HIV Medicine explored how stigma has played a role and been a major barrier in uptake and adherence of oral PrEP.
Clinical Practice Guidelines for Providing the PrEP Ring to Pregnant and Breastfeeding People (French)
These clinical guidelines support implementers to provide the PrEP ring to pregnant and breastfeeding people (PBFP). For the full Clinical Guidelines and Training Package for PrEP for PBFP, click here. This document is in French. For the English version, please click here.
Report: Formative research on CAB for PrEP in Eswatini
The goal of this study was to assess access needs, product acceptability, values, and preferences for the new PrEP method. This activity was a collaboration between EpiC and MOSAIC, and included adolescent girls and young women, men who have sex with men, people who inject drugs, female sex workers, pregnant and breastfeeding populations, and transgender…
Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction Report
This report was from the BioPIC Think Tank, Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction. As new HIV prevention products move closer to entering the market, there is an opportunity to design choice-based programs that apply lessons and successes from HIV and FP…
Safety and Efficacy of Long-Acting Injectable Cabotegravir as Preexposure Prophylaxis To Prevent HIV Acquisition
This journal article from AIDS reviewed existing evidence to determine the efficacy and safety of CAB for PrEP in order to inform global guidelines.
Important Steps for PrEP Uptake Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil
This journal article from PLOS ONE analyzed the PrEP uptake process and factors associated with daily oral PrEP initiation among adolescent men who have sex with men and transgender women in Brazil.
HIV Care Providers’ Familiarity, Concerns, and Attitudes About HIV PrEP in Colombia: Insights From the PrEP-Col-Study
This journal article from AIDS Care examined PrEP awareness and familiarity, comfort with PrEP-related activities, perceived barriers for PrEP implementation, concerns, and attitudes in Colombia.